How much funding has Affinivax raised?

Affinivax has raised $348.5M in total funding, most recently a Series C round.

Where is Affinivax headquartered?

Affinivax is headquartered in Cambridge, Massachusetts, United States.

What industry is Affinivax in?

Affinivax operates in Biotech, Healthcare.

How many employees does Affinivax have?

Affinivax has 51-200 employees.

Affinivax

Acquired

Cambridge, United States · Founded 2014 · $348.5M raised

Biotech

Healthcare

Headquarters: Cambridge, Massachusetts
Employees: 51–200
Founded: 2014
Business Model: B2B
Website: affinivax.com

Total Funding: $348.5M
Last Round: $226.0M Series CJan 2021
Rounds: 4
Acquisition Date: May 2022

About

Affinivax was a Cambridge, Massachusetts-based clinical-stage biotechnology company founded in 2014, pioneering the Multiple Antigen Presenting System (MAPS) platform technology for next-generation vaccines. Its lead asset, a 24-valent pneumococcal vaccine (AFX3772), received FDA Breakthrough Therapy designation and was in Phase II trials when GSK acquired the company for $2.1 billion upfront in August 2022.

Summary

Affinivax is a Biotech company based in Cambridge, United States, founded in 2014. It has raised $348.5M in total across 4 rounds, most recently a $226.0M Series C round in Jan 2021.

LinkedIn X (Twitter)